{
    "Trade/Device Name(s)": [
        "GlucoSure ADVANCE Link Blood Glucose Monitoring System",
        "GlucoSure ADVANCE Link Blood Glucose Meter",
        "GlucoSure ADVANCE Link Blood Glucose Test Strips",
        "Contrex Plus 5 Glucose Control Solution"
    ],
    "Submitter Information": "Apex BioTechnology Corp.",
    "510(k) Number": "K222234",
    "Predicate Device Reference 510(k) Number(s)": [
        "K161299"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "December 21, 2022",
    "Summary Letter Received Date": "July 26, 2022",
    "Submission Date": "July 25, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoSure ADVANCE Link Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoSure ADVANCE Link Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood with Bluetooth data transfer capability",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood by self-testers at home",
    "fda_folder": "Clinical Chemistry"
}